Literature DB >> 22453976

Calcium signaling in osteoclast differentiation and bone resorption.

Hiroshi Kajiya1.   

Abstract

Calcium (Ca(2+)) signaling controls multiple cellular functions and is regulated by the release of Ca(2+) from internal stores and its entry from the extracellular fluid. Ca(2+) signals in osteoclasts are essential for diverse cellular functions including differentiation, bone resorption and gene transcription. Recent studies have highlighted the importance of intracellular Ca(2+) signaling for osteoclast differentiation. Receptor activator of NF-κB ligand (RANKL) signaling induces oscillatory changes in intracellular Ca(2+) concentrations, resulting in Ca(2+)/calcineurin-dependent dephosphorylation and activation of nuclear factor of activated T cells c1 (NFATc1), which translocates to the nucleus and induces osteoclast-specific gene transcription to allow differentiation of osteoclasts. Recently, some reports indicated that RANKL-induced Ca(2+) oscillation involved not only repetitive intracellular Ca(2+) release from inositol 1, 4, 5-triphosphate channels in Ca(2+) store sites, but also via store-operated Ca(2+) entry and Ca(2+) entry via transient receptor potential V channels during osteoclast differentiation. Ca(2+)-regulatory cytokines and elevation of extracellular Ca(2+) concentrations have been shown to increase intracellular Ca(2+) concentrations ([Ca(2+)](i)) in mature osteoclasts, regulating diverse cellular functions. RANKL-induced [Ca(2+)](i) increase has been reported to inhibit cell motility and the resorption of cytoskeletal structures in mature osteoclasts, resulting in suppression of bone-resorption activity. In conclusion, Ca(2+) signaling activates differentiation in osteoclast precursors but suppresses resorption in mature osteoclasts. This chapter focuses on the roles of long-term Ca(2+) oscillations in differentiation and of short-term Ca(2+) increase in osteoclastic bone resorption activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22453976     DOI: 10.1007/978-94-007-2888-2_41

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  28 in total

Review 1.  Bone biology: insights from osteogenesis imperfecta and related rare fragility syndromes.

Authors:  Roberta Besio; Chi-Wing Chow; Francesca Tonelli; Joan C Marini; Antonella Forlino
Journal:  FEBS J       Date:  2019-07-05       Impact factor: 5.542

2.  Glechoma hederacea Suppresses RANKL-mediated Osteoclastogenesis.

Authors:  J K Hwang; M Erkhembaatar; D R Gu; S H Lee; C H Lee; D M Shin; Y R Lee; M S Kim
Journal:  J Dent Res       Date:  2014-05-21       Impact factor: 6.116

Review 3.  The roles of Orai and Stim in bone health and disease.

Authors:  Lisa J Robinson; Harry C Blair; John B Barnett; Jonathan Soboloff
Journal:  Cell Calcium       Date:  2019-06-05       Impact factor: 6.817

Review 4.  Calcium channels: the potential therapeutic targets for inflammatory bone destruction of rheumatoid arthritis.

Authors:  Robin Park; Jong Dae Ji
Journal:  Inflamm Res       Date:  2016-02-06       Impact factor: 4.575

5.  CDDO-Me, Sulforaphane and tBHQ attenuate the RANKL-induced osteoclast differentiation via activating the NRF2-mediated antioxidant response.

Authors:  Peng Xue; Xiangxiang Hu; James Powers; Nicole Nay; Emily Chang; Jane Kwon; Sing Wai Wong; Lichi Han; Tai-Hsien Wu; Dong-Joon Lee; Henry Tseng; Ching-Chang Ko
Journal:  Biochem Biophys Res Commun       Date:  2019-02-27       Impact factor: 3.575

6.  Deciphering the pharmacological mechanism of Guan-Jie-Kang in treating rat adjuvant-induced arthritis using omics analysis.

Authors:  Hudan Pan; Yanfang Zheng; Zhongqiu Liu; Zhongwen Yuan; Rutong Ren; Hua Zhou; Ying Xie; Liang Liu
Journal:  Front Med       Date:  2019-05-14       Impact factor: 4.592

7.  Unexpected Role of Matrix Gla Protein in Osteoclasts: Inhibiting Osteoclast Differentiation and Bone Resorption.

Authors:  Yan Zhang; Liting Zhao; Naining Wang; Jing Li; Fang He; Xu Li; Shufang Wu
Journal:  Mol Cell Biol       Date:  2019-05-28       Impact factor: 4.272

8.  Nucleus pulposus cells derived IGF-1 and MCP-1 enhance osteoclastogenesis and vertebrae disruption in lumbar disc herniation.

Authors:  Zhongjiao Zhu; Peng Huang; Yanxue Chong; Suraj K George; Bingtao Wen; Na Han; Zhiqiang Liu; Lixin Kang; Nie Lin
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

9.  Biogenic silica-metal phosphate (metal = Ca, Fe or Zn) nanocomposites: fabrication from rice husk and their biomedical applications.

Authors:  Jegan Athinarayanan; Vaiyapuri Subbarayan Periasamy; Ali A Alshatwi
Journal:  J Mater Sci Mater Med       Date:  2014-04-18       Impact factor: 3.896

10.  Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.

Authors:  C Dou; Y Chen; N Ding; N Li; H Jiang; C Zhao; F Kang; Z Cao; H Quan; F Luo; J Xu; S Dong
Journal:  Osteoporos Int       Date:  2016-01-25       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.